Piper Sandler reiterates Overweight on Axsome Therapeutics, $258 target
Piper Sandler reiterated an Overweight rating on Axsome Therapeutics and set a $258.00 price target, implying 20.4% upside versus the Sep 17 close of $214.28.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.